Results about: immunotherapy
High-ranking figures from the business and innovation sectors attended an event organised by IRB Barcelona and ESADE with the aim to highlight the importance of uniting all sectors of society against metastasis.
Advances in research into the immunological evasion, metabolism and latency of metastatic cancer cells allow the identification of potential targets to test therapies.
IRB Barcelona and the BBVA Foundation invite 20 renowned international scientists working in the field of cancer metastasis to a gathering in Barcelona.
After the scientific conference, IRB Barcelona and ESADE have organised a debate on how to translate scientific research to society.
Gonzalo Fernández-Miranda, associate researcher at IRB Barcelona, leads this therapeutic project selected by CaixaImpulse to facilitate its development towards the market.
Olga Torres Foundation awards IRB Barcelona a grant to study immunotherapies for metastatic colorectal cancer
The project, headed by group leader and ICREA researcher Eduard Batlle, receives a 60,000-€ grant.
The study will test the effectiveness of immunotherapies to treat metastatic disease in advanced colorectal cancer.
Research will take place during the academic years 2017 and 2018.